Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm
Philip A Beer, Francois Delhommeau, Jean-Pierre LeCouedic, Mark A Dawson, Edwin Chen, David Bareford, Rajko Kusec, Mary Frances McMullin, Claire N Harrison, Alessandro M Vannucchi, William Vainchenker, Anthony R Green
Blood | AMER SOC HEMATOLOGY | Published : 2010
Awarded by Cancer Research UK
Awarded by Medical Research Council
This work was supported by the UK Medical Research Council, the Leukaemia Research Fund, the Kay Kendall Leukaemia Fund, the NIHR Cambridge Biomedical Research Centre, the Leukemia & Lymphoma Society of America, the Myeloproliferative Disorders Foundation, the Laurette Fugain Association, the Fondation de France, the Ligue Nationale Contre le Cancer, and the Canceropole Ile de France.